Pharmaceutical Continuous Manufacturing Market by Product (Integrated Continuous Systems, Semicontinuous Systems, and Control & Software), Application (Final Drug Product Manufacturing and API Manufacturing), and End User (Pharmaceutical Companies, Contract Manufacturing Organizations, and Others): Global Opportunity Analysis and Industry Forecast, 20192026
- Published Date: 2020-10-18
- Report ID: 3890
- Pages: 245
-
Format:
The global pharmaceutical continuous manufacturing market was valued at $393 million in 2018, and is projected to reach $855 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.
Continuous manufacturing is advanced manufacturing approach that is performed by employing end-to-end integration of manufacturing subprocesses with a significant level of control strategies.
The growth of the global pharmaceutical continuous manufacturing market is anticipated to be driven by increase in adoption of continuous manufacturing systems over existing drug manufacturing process, technological advancements in CM systems, and rise in awareness of continuous manufacturing systems in developing regions are anticipated to significantly boost the growth of the pharmaceutical continuous manufacturing market during the forecast period. Continuous pharmaceutical manufacturing system offers advantages such as reduced fluctuation in production, improved yields, lower cost of operation & equipment further augment the market growth.
Moreover, initiatives taken by the Food and drug Administration (FDA) for promoting the use of pharmaceutical continuous manufacturing systems and advantage of CM systems over the batch manufacturing are the major factors to boost the growth of pharmaceutical continuous manufacturing market. However, higher cost of pharmaceutical continuous manufacturing systems impede the market growth.
Moreover, the CM process is more time-efficient, reduces energy needs, helps to increase productivity, and minimizes overall waste, which are expected to offer lucrative opportunity for the pharmaceutical continuous manufacturing market during the forecast period.
The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and region. On the basis of product, the market is classified into integrated continuous systems, semicontinuous systems, and control & software. By application, it is divided into final drug product manufacturing and API manufacturing. Depending on end user, it is categorized into pharmaceutical companies, contract manufacturing organizations, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of four major regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
o Integrated Continuous Systems
o Semicontinuous Systems
o Control & Software
Application Type
o Final Drug Product Manufacturing
o API Manufacturing
End User
o Pharmaceutical Companies
o Contract Manufacturing Organizations
o Others
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Rest of Europe
Asia-Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Bosch Packaging Technology
Coperion GmbH
GEA Group AG
Gebrder Ldige Maschinenbau GmbH
Glatt GmbH
Hosokawa Micron Corporation
Korsch AG
L.B. Bohle Maschinen + Verfahren GmbH
Munson Machinery Company, Inc.
Thermo Fisher Scientific Inc.
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models
Chapter 2: Executive Summary
2.1. Key Findings of The Study
2.2. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Market Player Positioning, 2018
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Increase In Government Support For Continuous Manufacturing Adoption
3.3.1.2. Advantages offered By Continuous Manufacturing Systems
3.3.1.3. Surge In Adoption of Pharmaceutical Continuous Manufacturing Systems
3.3.2. Restraint
3.3.2.1. Poor Demand In Under Developed Countries
3.3.3. Opportunities
3.3.3.1. Growth Opportunities In Emerging Markets
3.3.4. Impact Analysis
Chapter 4: Pharmaceutical Continuous Manufacturing Market, By Product
4.1. Overview
4.1.1. Market Size And Forecast
4.2. Integrated Continuous Systems
4.2.1. Key Market Trends And Opportunities
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3. Semi-Continuous Systems
4.3.1. Key Market Trends And Opportunities
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4. Control & Software
4.4.1. Key Market Trends And Opportunities
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
Chapter 5: Pharmaceutical Continuous Manufacturing Market, By Application
5.1. Overview
5.1.1. Market Size And Forecast
5.2. Final Drug Product Manufacturing
5.2.1. Market Size And Forecast
5.2.2. Market Analysis, By Country
5.3. Api Manufacturing
5.3.1. Market Size And Forecast
5.3.2. Market Analysis, By Country
Chapter 6: Pharmaceutical Continuous Manufacturing Market, By End User
6.1. Overview
6.1.1. Market Size And Forecast
6.2. Pharmaceutical Companies
6.2.1. Market Size And Forecast
6.2.2. Market Analysis, By Country
6.3. Contract Manufacturing Organizations
6.3.1. Market Size And Forecast
6.3.2. Market Analysis, By Country
6.4. Others
6.4.1. Market Size And Forecast
6.4.2. Market Analysis, By Country
Chapter 7: Pharmaceutical Continuous Manufacturing Market, By Region
7.1. Overview
7.1.1. Market Size And Forecast
7.2. North America
7.2.1. Key Market Trends, Growth Factors, And Opportunities
7.2.2. Market Size And Forecast, By Country
7.2.2.1. U.S.
7.2.2.1.1. U.S. Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.1.2. U.S. Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.1.3. U.S. Pharmaceutical Continuous Manufacturing Market, By End User
7.2.2.2. Canada
7.2.2.2.1. Canada Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.2.2. Canada Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.2.3. Canada Pharmaceutical Continuous Manufacturing Market, By End User
7.2.2.3. Mexico
7.2.2.3.1. Mexico Pharmaceutical Continuous Manufacturing Market, By Product
7.2.2.3.2. Mexico Pharmaceutical Continuous Manufacturing Market, By Application
7.2.2.3.3. Mexico Pharmaceutical Continuous Manufacturing Market, By End User
7.2.3. North America Market Size And Forecast, By Product
7.2.4. North America Market Size And Forecast, By Application
7.2.5. North America Market Size And Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends, Growth Factors, And Opportunities
7.3.2. Market Size And Forecast, By Country
7.3.2.1. Germany
7.3.2.1.1. Germany Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.1.2. Germany Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.1.3. Germany Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.2. France
7.3.2.2.1. France Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.2.2. France Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.2.3. France Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.3. Uk
7.3.2.3.1. Uk Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.3.2. Uk Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.3.3. Uk Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.4. Italy
7.3.2.4.1. Italy Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.4.2. Italy Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.4.3. Italy Pharmaceutical Continuous Manufacturing Market, By End User
7.3.2.5. Rest of Europe
7.3.2.5.1. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product
7.3.2.5.2. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application
7.3.2.5.3. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User
7.3.3. Europe Market Size And Forecast, By Product
7.3.4. Europe Market Size And Forecast, By Application
7.3.5. Europe Market Size And Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends, Growth Factors, And Opportunities
7.4.2. Market Size And Forecast, By Country
7.4.2.1. Japan
7.4.2.1.1. Japan Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.1.2. Japan Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.1.3. Japan Pharmaceutical Continuous Manufacturing Market, By End User
7.4.2.2. China
7.4.2.2.1. China Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.2.2. China Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.2.3. China Pharmaceutical Continuous Manufacturing Market, By End User
7.4.2.3. India
7.4.2.3.1. India Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.3.2. India Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.3.3. India Pharmaceutical Continuous Manufacturing Market, By End User
7.4.2.4. Rest of Asia-Pacific
7.4.2.4.1. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product
7.4.2.4.2. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application
7.4.2.4.3. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User
7.4.3. Asia-Pacific Market Size And Forecast, By Product
7.4.4. Asia-Pacific Market Size And Forecast, By Application
7.4.5. Asia-Pacific Market Size And Forecast, By End User
7.5. Lamea
7.5.1. Key Market Trends, Growth Factors, And Opportunities
7.5.2. Market Size And Forecast, By Country
7.5.2.1. Brazil
7.5.2.1.1. Brazil Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.1.2. Brazil Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.1.3. Brazil Pharmaceutical Continuous Manufacturing Market, By End User
7.5.2.2. South Africa
7.5.2.2.1. South Africa Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.2.2. South Africa Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.2.3. South Africa Pharmaceutical Continuous Manufacturing Market, By End User
7.5.2.3. Saudi Arabia
7.5.2.3.1. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.3.2. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.3.3. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User
7.5.2.4. Rest of Lamea
7.5.2.4.1. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product
7.5.2.4.2. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application
7.5.2.4.3. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User
7.5.3. Lamea Market Size And Forecast, By Product
7.5.4. Lamea Market Size And Forecast, By Application
7.5.5. Lamea Market Size And Forecast, By End User
Chapter 8: Company Profiles
8.1. Coperion Gmbh
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Product Portfolio
8.1.5. Key Strategic Moves And Developments
8.2. Gea Group Ag
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Product Portfolio
8.2.5. Business Performance
8.3. Gebrder Ldige Maschinenbau Gmbh
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Product Portfolio
8.4. Glatt Gmbh
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Product Portfolio
8.5. Hosokawa Micron Corporation
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Product Portfolio
8.5.4. Business Performance
8.6. Korsch Ag
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Product Portfolio
8.7. L.B. Bohle Maschinen + Verfahren Gmbh
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Product Portfolio
8.8. Munson Machinery Company, Inc.
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Product Portfolio
8.9. Robert Bosch Packaging Technology Gmbh
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Operating Business Segments
8.9.4. Product Portfolio
8.9.5. Business Performance
8.10. Thermo Fisher Scientific, Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Product Portfolio
8.10.5. Business Performance
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
